US Neurotechnology Market Research Report Forecast to 2040
Neurotechnology is a broad term that encompasses any technology that interfaces with the nervous system to monitor or modulate neural activity. This can be done for a variety of purposes, including research, diagnosis & treatment, and enhancement. Furthermore, neurotechnologies can be invasive or non-invasive. Invasive neurotechnologies require the implantation of electrodes or other devices into the brain or nervous system. Non-invasive neurotechnologies do not require implantation, such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI).
The US neurotechnology market is predicted to expand due to growing incidence of neurological disorders and increasing number of geriatric populations, and rapid advancements in technology, However, cost of development and implementation are limiting market expansion. Personalized medicine, on the other hand, boosts the market's attractiveness. Another aspect driving market expansion is the increasing government investment in healthcare infrastructures.
Market Segmentation
Based on the technology, the market has been segmented into neurosensing, neurostimulation, neuroprosthese and neurorehabilitation.
Based on the indication, the market has been segmented into cognitive disorders, pain treatment, epilepsy, Parkinson’s disease, depression, and others.
Based on test type, US neurotechnology market has been segmented into hospitals & clinics, ambulatory surgical centers, academic & research laboratories, specialty clinics, and homecare.
Major Players
The key market players in the US Neurotechnology market are Medtronic, Boston Scientific Corporation, Abbott Laboratories, Inc., Cochlear Ltd., Shimadzu Corporation, and Neuronetics
Companies Mentioned
Medtronic Boston Scientific Corporation Abbott Laboratories Inc. Cochlear Ltd. Shimadzu Corporation and Neuronetics
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Technique
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Incidence Of Neurological Disorders
4.2.2 Increasing Number Of Geriatric Population
4.2.3 Rapid Advancements In Technology
4.3 Restraints
4.3.1 Cost Of Development And Implementation
4.4 Opportunity
4.4.1 Personalized Medicine Creating Promising Opportunity For Neurotechnology Market
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution And Sales
5.1.4 Post-sales Monitoring
5.2 Porter’s Five Forces Model
5.2.1 Threat Of New Entrants
5.2.2 Bargaining Power Of Suppliers
5.2.3 Threat Of Substitutes
5.2.4 Bargaining Power Of Buyers
5.2.5 Intensity Of Rivalry
5.3 Impact Of Covid-19 On The Us Neurotechnology Market
5.3.1 Impact On Supply Chain
5.3.2 Impact On Key Players
6 Us Neurotechnology Market, By Technology
6.1 Overview
7 Us Neurotechnology Market, By Indication
7.1 Overview
8 Us Neurotechnology Market, By End User
8.1 Overview
9 Competitive Landscape
9.1 Introduction
9.2 Market Share Analysis, 2022
9.3 Competitor Dashboard
9.4 Public Players Stock Summary
9.5 Comparative Analysis: Key Players Financial
9.6 Key Developments & Growth Strategies
9.6.1 Product Launch/Product Approval
9.6.2 Partnership/Investment/Collaboration
10 Company Profiles
10.1 Medtronic
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offered
10.1.4 Key Developments
10.1.5 Swot Analysis
10.1.6 Key Strategies
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offered
10.2.4 Key Developments
10.2.5 Swot Analysis
10.2.6 Key Strategies
10.3 Neuronetics
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products Offered
10.3.4 Key Developments
10.3.5 Key Strategies
10.4 Mindmaze
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offered
10.4.4 Key Developments
10.4.5 Key Strategy
10.5 Shimadzu Corporation
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offered
10.5.4 Key Developments
10.5.5 Swot Analysis
10.5.6 Key Strategy
10.6 Abbott Laboratories, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offered
10.6.4 Key Developments
10.6.5 Key Developments
10.6.6 Swot Analysis
10.6.7 Key Strategies
10.7 Cochlear Ltd.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offered
10.7.4 Key Developments
10.7.5 Swot Analysis
10.7.6 Key Strategies
10.8 Synchron
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offered
10.8.4 Key Developments
10.8.5 Key Strategies
10.9 Neofect
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offered
10.9.4 Key Developments
10.9.5 Key Strategies
10.10 Rehabtronics Inc
10.10.1 Company Overview
10.10.2 Inancial Overview
10.10.3 Products Offered
10.10.4 Key Developments
10.10.5 Key Strategies
11 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Us Neurotechnology Market, By Technology, 2019–2040 (Usd Million)
Table 3 Us Neurotechnology Market, By Indication, 2019–2040 (Usd Million)
Table 4 Us Neurotechnology Market, By End User, 2019–2040 (Usd Million)